Griffith University
Continue with FacebookLooking to list your PhD opportunities? Log in here.
infectious PhD Projects, Programmes & Scholarships
We have 72 infectious PhD Projects, Programmes & Scholarships
PhD saved successfully
Controlling airborne infectious disease transmission in indoor environment
Infectious disease pandemics are brutal killers in human history. The recent COVID-19 outbreak in China has killed over 2.4K people globally, and more than 78K people are infected across 28 countries (As of 22th Feb 2020). Read more
Establishing an effective 3D cell culture model for the study of infectious respiratory diseases
Infectious respiratory diseases pose serious threats to human and animal health due to their high mortality and morbidity rates. Lung structure and composition varies between species. Read more
Mathematical modelling of transmission and worldwide distribution of neglected zoonotic diseases (Q fever)
A 3-year fully funded position is available to contribute substantially to the development of a new modelling approach for the prediction and control of zoonotic diseases (Q fever). Read more
Manipulation of neuroimmune responses and behaviour by infectious agents
This project is available exclusively to self-funded students who wish to commence study for a PhD in the academic year 2023/24. The project focuses on how infectious agents modify the individuals that they infect and how neuroimmune responses to infection moderate behaviour changes in warm-blooded animals and humans. Read more
Helminth products as macrophage “trainers”: a novel therapeutic tool for the treatment of immune mediated diseases
The innate immune system can display characteristics of immunological memory. This phenomenon, termed “trained immunity”, refers to the long-term functional reprogramming of innate immune cells after the encounter with infectious or non-infectious agents that influences their capacity to respond to a secondary stimulus. Read more
Identify novel approaches to combat multi drug resistant pathogens
Our research is focused on recalcitrant ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, andEnterobacter species) pathogens; especially hard-to-treat clinical isolates involved in multidrug resistance, biofilm infections and persistence. Read more
Informing transboundary disease spread with animal movement technology
This fully funded 3.5 year PhD training programme provides unique inter-disciplinary training in transboundary disease epidemiology, mathematical modelling and statistics, animal movement, and health economics. Read more
Bayesian Computation for Epidemic Models
Mathematical models of infectious disease transmission continue to play a vital role in understanding, mitigating, and preventing outbreaks. Read more
Study at Griffith University’s Institute for Glycomics and help fight diseases of global impact
Did you know that more than 17 million people die from infectious diseases and over 9 million people die from cancer every year across the world?. Read more
High throughput screening models for intracellular delivery of antimicrobial nanotherapeutics
Fungal and bacterial infections contribute to over 7 million deaths yearly, affecting over 300 million people globally (GAFFI). Read more
Digital design and advanced processing technologies for antimicrobial nanotherapeutics
Fungal and bacterial infections contribute to over 7 million deaths yearly, affecting over 300 million people globally (GAFFI). Read more
Pandemic Potential of Avian Influenza in the UK: Modelling Cross-Species Transmission and Spillover to Humans
The 2022 Avian Influenza outbreak in the UK is largest on record and the first time farm-to-farm transmission and animal-to-human transmission has been identified[1]. Read more
Engineering biosensors for the detection of bacterial proteins
Superbug outbreaks are more likely to occur in a healthcare environment and are causing an increasing number of deaths every year. Read more
Cell biology underlying host-mycobacterium interactions
TB remains the world’s greatest infectious killer despite a vaccine (BCG) for a century and effective antibiotics for 60 years. TB’s persistence over millennia in the face of major medical advances underscores the ability of Mycobacterium tuberculosis to evade and exploit host defences and antibiotics. Read more
Neuroimmune crosstalk in infection and cancer
Immune reactions against pathogens and tumours require several layers of regulation to ensure the appropriate control of infectious agents and cancerous… Read more
